The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety US$ 24.37 Min. order: 1 piece ★★★★★ 4.1 (15 reviews) Sold : Login>>
New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide– Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) US$ 27.90 Min. order: 1 piece ★★★★★ 4.0 (228 reviews) Sold : Login>>
Cagrilintide/Semaglutide 2.4/2.4 Or 5/5 US$ 21.32 Min. order: 1 piece ★★★★★ 4.9 (47 reviews) Sold : Login>>
Cagrilintide + Semaglutide – Peptide Research Blend – PRG US$ 26.76 Min. order: 1 piece ★★★★★ 4.4 (53 reviews) Sold : Login>>